The LLR TAP IcICLLe trial assessing biological response to ibrutinib in CLL: Immediate disease redistribution precedes cell cycle arrest by 2 weeks with reduced bone marrow infiltration by 6 months
Authors
Munir, TRawstron, A
Dalal, S
de Tute, R
Brock, K
Yates, F
McDonald, D
Fegen, C
Bloor, Adrian
Hillman, P
Affiliation
Leeds Teaching Hospitals, LeedsIssue Date
2016